Quote from Informed:
Suggest short May at money straddles to take advantage of the high premiums. I predict FDA will approve, but the share price won't move above 50.
Target price
Approval 50 (50%)
Approval with tough restriction or post approval study 45 (25%)
Request more data but no more new trial 38 or other delay (20%)
More data new trial 22 (5%)
LOL. Yep. Dubya coined that Bushism in the 2000 campaign and it has been parodied on You Tube, Saturday Night Live, etc.Quote from jprad:
There's more than one?
If you have reason to believe that it's not going lower, take a look at call premiums first thing this AM. If by some chance they haven't totally imploded (IV not totally in the crapper), you may have some salvage possibilities.Quote from highseas:
Any suggestions as to what the next step is? Take the shares? (maybe not the $15, but perhaps $12.5 and $10 if assigned by May expiry).
